ATXN10 Protein

ATXN10 Protein

Overview

Atxn10 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Ataxin-10 (ATXN10) is a 47.5 kDa protein encoded by the ATXN10 gene, belonging to the ataxin family of proteins characterized by polyglutamine expansions in various spinocerebellar ataxias. Originally identified as the causative protein in Spinocerebellar Ataxia Type 10 (SCA10), ataxin-10 has emerged as a protein with broader implications in neuronal function and multiple neurodegenerative diseases. This page provides comprehensive information about ataxin-10's structure, molecular functions, protein interactions, and its role in neurodegenerative disease pathogenesis.

ATXN10 Protein

Overview

Atxn10 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Ataxin-10 (ATXN10) is a 47.5 kDa protein encoded by the ATXN10 gene, belonging to the ataxin family of proteins characterized by polyglutamine expansions in various spinocerebellar ataxias. Originally identified as the causative protein in Spinocerebellar Ataxia Type 10 (SCA10), ataxin-10 has emerged as a protein with broader implications in neuronal function and multiple neurodegenerative diseases. This page provides comprehensive information about ataxin-10's structure, molecular functions, protein interactions, and its role in neurodegenerative disease pathogenesis.

<div class="infobox .infobox-protein">
<h3>ATXN10 Protein</h3>
<table>
<tr><th>Protein Name</th><td>Ataxin-10</td></tr>
<tr><th>Gene</th><td>[ATXN10](/genes/atxn10)</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/Q9UBB4" target="_blank">Q9UBB4</a></td></tr>
<tr><th>PDB ID</th><td>2JOB, 2MSU</td></tr>
<tr><th>Molecular Weight</th><td>47.5 kDa</td></tr>
<tr><th>Amino Acids</th><td>424</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm, Endoplasmic Reticulum</td></tr>
<tr><th>Protein Family</th><td>Ataxin family</td></tr>
<tr><th>Domain Architecture</th><td>Armadillo repeats</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Structure

Ataxin-10 possesses a distinctive domain architecture that underlies its molecular functions:

Primary Structure

• N-terminal domain: Contains glutamine-rich (Q-rich) sequences that undergo pathological expansion in SCA10 patients
• Central region: Houses multiple armadillo (ARM) repeats, which mediate protein-protein interactions
• C-terminal domain: Predominantly alpha-helical structure

Three-Dimensional Structure

The armadillo repeats of ataxin-10 form a superhelical structure that creates a large interaction surface for binding various partner proteins[@mcgough2019]. This structural organization allows ataxin-10 to function as a scaffolding protein, bringing together multiple signaling components. The protein adopts a predominantly alpha-helical conformation, with the ARM domain forming a right-handed superhelix[@chen2005].

Post-Translational Modifications

• Phosphorylation: Can be phosphorylated at serine and threonine residues, affecting its subcellular localization and protein interactions
• Ubiquitination: Subject to ubiquitin-mediated degradation, regulating protein turnover
• SUMOylation: Potential SUMOylation sites may modulate nuclear-cytoplasmic shuttling

Normal Physiological Function

Ataxin-10 performs essential functions in neuronal cells that are critical for cellular homeostasis and survival:

1. Neuronal Survival and Anti-apoptotic Activity

Ataxin-10 exhibits neuroprotective properties through multiple mechanisms:

• Inhibition of [apoptosis](/entities/apoptosis): Ataxin-10 interacts with pro-apoptotic proteins and suppresses caspase-dependent cell death pathways[@liu2009]
• Mitochondrial protection: The protein localizes to mitochondria and helps maintain mitochondrial membrane potential
• Stress response: Ataxin-10 participates in cellular stress response pathways, including response to oxidative stress

2. Protein Phosphatase 2A (PP2A) Regulation

One of the most well-characterized functions of ataxin-10 is its interaction with [PP2A](/entities/pp2a):

• PP2A activation: Ataxin-10 directly binds to and activates the PP2A signaling cascade[@liu2018]
• [Tau](/proteins/tau) dephosphorylation: Through PP2A activation, ataxin-10 promotes tau dephosphorylation, potentially protecting against tau pathology
• Synaptic function: PP2A-dependent signaling regulates synaptic plasticity and neurotransmitter release

3. Calcium Homeostasis

Ataxin-10 plays a critical role in neuronal calcium regulation:

• ER calcium release: Modulates inositol trisphosphate (IP3) receptor-mediated calcium release from the endoplasmic reticulum[@bezprozvanny2009]
• Mitochondrial calcium uptake: Regulates mitochondrial calcium uptake through the mitochondrial calcium uniporter (MCU) complex
• Calcium-dependent signaling: Influences calcineurin and calcium/calmodulin-dependent protein kinase (CaMK) pathways

4. mRNA Translation Regulation

• Translation initiation: Ataxin-10 associates with translation initiation complexes and modulates protein synthesis
• Neuronal protein homeostasis: Helps maintain proper neuronal protein synthesis, crucial for synaptic plasticity
• Stress granule formation: Involved in stress response and mRNA granule dynamics

5. ER-Mitochondria Communication

• MAM formation: Ataxin-10 localizes to mitochondria-associated membranes (MAMs), which are ER-mitochondria contact sites critical for calcium signaling, lipid transfer, and apoptosis regulation[@hayashi2009]
• Calcium transfer: Facilitates calcium transfer between ER and mitochondria
• Apoptosis regulation: MAMs are pivotal platforms for apoptosis initiation; ataxin-10's presence affects this process

Role in Neurodegeneration

Spinocerebellar Ataxia Type 10 (SCA10)

SCA10 is an autosomal dominant neurodegenerative disorder caused by ATTCT pentanucleotide repeat expansions in the ATXN10 gene:

Genetics

• Repeat expansion: 80-4500 ATTCT repeats in intron 9 cause the disease
• Anticipation: Earlier onset in successive generations due to repeat instability
• Founder effect: Primarily found in families of Mexican descent

Pathogenic Mechanisms

RNA-mediated toxicity:

• Expanded RNA forms toxic foci in neuronal nuclei
• Sequestration of RNA-binding proteins disrupts splicing and transcription
• Dysregulation of neuronal gene expression

• Reduced ataxin-10 protein levels due to repeat-induced degradation
• Impaired PP2A activation leads to tau hyperphosphorylation
• Mitochondrial dysfunction due to loss of ataxin-10 protective functions

• Production of toxic polyglutamine proteins from the expanded repeat
• Aberrant protein aggregation in [neurons](/entities/neurons)

Clinical Manifestations

• Progressive cerebellar ataxia (gait and limb incoordination)
• Epilepsy (particularly generalized seizures)
• Ophthalmoplegia (eye movement abnormalities)
• Peripheral neuropathy
• Cognitive decline in some patients

Alzheimer's Disease

Ataxin-10 has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:

• Tau pathology: Reduced ataxin-10 leads to decreased PP2A activity and tau hyperphosphorylation[@rossi2015]
• Synaptic dysfunction: Loss of ataxin-10 affects synaptic plasticity and memory formation
• Amyloid interaction: [Aβ](/proteins/amyloid-beta) exposure downregulates ataxin-10 expression in neuronal cultures
• Therapeutic potential: Enhancing ataxin-10 expression or activity may protect against AD pathology

Parkinson's Disease

• Dopaminergic neuron vulnerability: Ataxin-10 is expressed in substantia nigra dopaminergic neurons
• Mitochondrial dysfunction: Loss of ataxin-10 exacerbates mitochondrial dysfunction in PD models[@van2020]
• [LRRK2](/entities/lrrk2) interaction: Potential interaction with LRRK2, a major PD causative gene
• [α-Synuclein](/proteins/alpha-synuclein) pathology: May influence α-synuclein aggregation and toxicity

Other Neurodegenerative Conditions

• Huntington's Disease: Ataxin-10 expression altered in HD models; potential therapeutic target
• Amyotrophic Lateral Sclerosis (ALS): Dysregulation of ataxin-10 in motor neuron disease
• Multiple System Atrophy (MSA): Cerebellar variant involves pathways affected by ataxin-10 dysfunction

Protein Interactions

Ataxin-10 interacts with numerous proteins that mediate its functions:

| Partner Protein | Interaction Type | Functional Consequence |
|-----------------|------------------|----------------------|
| PP2A (PPP2R2A) | Direct binding | Activation of tau dephosphorylation |
| IP3R | Regulatory | Modulation of calcium release |
| Bcl-2 | Anti-apoptotic | Inhibition of apoptosis |
| Hsp90 | Molecular chaperone | Protein folding stability |
| p53 | Transcriptional regulation | Apoptosis modulation |
| LRRK2 | Potential | [Parkinson's disease](/diseases/parkinsons-disease) link |

Therapeutic Implications

Understanding ataxin-10's role in neurodegeneration has opened therapeutic avenues:

1. SCA10 Therapeutic Strategies

• Antisense oligonucleotides: ASOs targeting mutant ATXN10 mRNA to reduce toxic protein
• Gene therapy: Viral vector-mediated delivery of wild-type ataxin-10
• Small molecules: Compounds promoting proper protein folding or reducing RNA toxicity
• Anti-epileptic drugs: Management of seizure manifestations

2. Broader Neurodegeneration Applications

• PP2A activators: Developing small molecules that mimic ataxin-10's PP2A-activating function[@voronkov2013]
• Mitochondrial protectors: Compounds preserving mitochondrial function
• Calcium stabilizers: Agents modulating calcium homeostasis
• Tau-targeted therapies: Anti-tau strategies based on PP2A modulation

Key Publications

Overview

Atxn10 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Atxn10 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Cross-references

• Gene: ATXN10
• Diseases: Spinocerebellar Ataxia Type 10, Alzheimer's Disease, Parkinson's Disease
• Pathways: Mitochondrial Dysfunction, Calcium Homeostasis, ER-Mitochondria Contact Sites, Apoptosis, Tau Pathology
• Proteins: PP2A, Bcl-2, p53
• Brain Regions: Cerebellum, Substantia Nigra

See Also

• [ATXN10 Gene](/genes/atxn10)
• [Spinocerebellar Ataxia](/cell-types/cerebellar-purkinje-ataxia)
• [Cerebellum](/brain-regions/cerebellum)
• [Ataxin Proteins](/content/proteins)

External Links

• [ATXN10 - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/6314)
• [Ataxin-10 - UniProt](https://www.uniprot.org/uniprot/Q9UBB4)
• [SCA10 - GeneReviews](https://www.ncbi.nlm.nih.gov/books/NBK1116/)
• [OMIM: Ataxin-10](https://www.omim.org/entry/603516)

References